Slides on SGLT2 Inhibitor Therapy in Type 2 Diabetes

Learn about the role of SGLT-2 inhibitors in treating type 2 diabetes.
Anne Peters, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.96 MB
Released: December 10, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

This activity is supported by an independent educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.

Related Content

Laurie Cohen, MD, on when and how to retest for GH deficiency, how soon to start GH replacement in cancer survivors from Clinical Care Options (CCO)

Laurie E. Cohen, MD Released: April 22, 2021

Danielle Friedman, MD, on adipose dysfunction, insulinopenia, obesity, and diabetes after irradiation in cancer survivors

Danielle N. Friedman, MD, MS Released: April 22, 2021

Kristina Utzschneider, MD: Incretins and GLP-1 RAs for weight loss–thoughts on dosing, switching, nausea, vomiting, pancreatitis, gallstones

Kristina M. Utzschneider, MD Released: April 12, 2021

Webcast from ENDO 2021, learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments

Wassim Chemaitilly, MD Laurie E. Cohen, MD Danielle N. Friedman, MD, MS Steven G. Waguespack, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits ABIM MOC: maximum of 1.5 Medical Knowledge MOC point(s) Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: March 22, 2021 Expired: February 28, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue